Abstract
Introduction
Over the past two decades, tissue engineering has been the focus of extensive research resulting in significant advances and clinically available products. A major challenge, however, lies in vascularization of large three-dimensional bioartificial constructs [1, 2] . Delivery of proangiogenic growth factors as proteins and via gene therapy as a means to stimulate angiogenesis in tissueengineered constructs in vitro and in vivo have been extensively studied in the past with a certain success [3, 4] . A problem of the growth factor delivery approach, however, lies in the fact that the number of endothelial cells that could be locally stimulated by angiogenic molecules is limited [5] . An alternative may thus be to supply appropriate cell populations towards the formation of new blood vessels [6] . 2453 
© 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd Endothelial progenitor cells (EPC) have been shown to play a key role in different disease states where (neo)-angiogenesis and -vasculogenesis occur in adulthood. This finding implies that formation of new blood vessels does not only occur by sprouting from pre-existing vessels (angiogenesis)
, but also under participation of these progenitor cells that circulate in the bloodstream and differentiate in situ, i.e. vasculogenesis [5] . Indeed, experimental studies have demonstrated that EPC are recruited from bone marrow and the bloodstream to areas of new blood vessel formation where they contribute to (neo)-vascularization after myocardial infarction, stroke, lower extremity ischemia as well as in tumours [7] . Based on studies like these, a new concept of 'therapeutic vasculogenesis' was developed that implies transplantation of EPC to enhance (neo)-vascularization of ischemic tissues [6] . [8] , knowledge about their usefulness in generating blood vessels in bioartificial tissues in vivo is limited [9] .
Although transplantation of EPC induced angiogenesis and vasculogenesis in a therapeutically efficient manner in a number of experimental and clinical studies aiming for blood vessel formation in ischemic tissues
Thus far, application of EPC has mostly been restricted to seeding on various three-dimensional matrices resulting in formation of capillary-like tubes in vitro [10] . We recently suspended the murine embryonal EPC line T17b (T17b EPC) [11] [3] . Moreover, morphological analysis showed formation of lumen-containing circular structures. The T17b EPC line is derived from murine embryos at Day E 7.5 and has been initially characterized by Hatzopoulos et al. [11] . T17b EPC display robust growth properties and stability of phenotype in vitro and have been extensively characterized in vitro [11, 12] and in vivo in several different animal models [12] [13] [14] [11, 12] and in vivo [12] [13] [14] [14] .
in a commercially available fibrin matrix and demonstrated that these cells could be induced towards proliferation as well as differentiation and vascular endothelial growth factor (VEGF) secretion after an incubation period of 8 days
In 
Fluorescence microscopy
Images were generated with a Leica microscope using 200ϫ magnification. Appropriate filter systems for detection of the triple fluorescence labelling was used (red -Di-I; green -BS-1 lectin; blue -DAPI). (Fig. 1) . (Fig. 2) . There was no significant influence on fibrin clot height at earlier explantation time-points days 3 and 7 (Fig. 2) . (Fig. 3) . (Fig. 4) . Fig. 6A-C Fig. 6D-F) . (Fig. 7A-C) .
Results

Surgery and animals
in either of the two groups (data not shown). Presence of blood vessels in granulation tissue was confirmed by specific immunohistochemical staining for BS-1 (Fig. 1). ED-1 immunohistochemical
Fig. 1 Representative micrographs of fibrovascular tissue adjacent to fibrin matrices and detection of blood vessel formation by immunohistochemical analysis. Endothelial cell lectin staining of cell-free constructs (A-C) and T17b EPC-containing constructs (D-F) at day 3 (A, D), day 7 (B, E) and 14 (C, F). Representative photographs of ED-1 staining of macrophage invasion at day 14 in cell-free constructs (G) compared to cell-containing constructs (H). Numbers of blood vessels were increased at day 3 (D versus A) and 7 (E versus B) when T17b EPC were present within the construct. Magnification ϫ200 (A-F) and ϫ400 (G, H). N ϭ 6 constructs per group and time-point.
© 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd staining was performed to assess if macrophage infiltration is increased after xenogenic transplantation of murine EPC into the rat host. At 14 days after implantation, representative micrographs failed to detect significantly altered levels of macrophage invasion into the newly formed fibrovascular tissue (Fig. 1). Lectin-stained cross-sections were used for morphometric analysis in terms of quantification of blood vessel formation within the fibrovascular granulation tissue adjacent to the fibrin clots
Morphometric analysis
Addition of T17b EPC resulted in a significantly increased degradation with consecutive reduction in fibrin clot height at 14 days after implantation
The use of EPC significantly increased height of fibrovascular tissue at 3 days, 7 days as well as 14 days compared to EPC-free controls
The total number of blood vessels counted in fibrovascular tissue adjacent to the matrices of lectin stained cross-sections was significantly increased after 3 and 7 days when T17b were present in the fibrin clot. At day 14, there was no significant difference in number of blood vessels
Conversely, the average size, i.e. the diameter of blood vessels in the fibrovascular tissue was significantly increased at all timepoints in EPC-containing clots (Fig. 5).
Fluorescence microscopy
Fluorescence microscopy showed that number of EPC within the fibrin clot decreased over the experiment. At day 3, Di-I ϩ EPC appear numerous within the clot, whereas their number decreases at day 7. At day 14 after implantation, only a small number of EPC is present within the fibrin clot (
Triple fluorescence microscopy for BS-1 lectin (labelling host rat endothelium and transplanted murine T17b EPC in green), Di-I (corresponding to pre-labelled murine T17b in red) and DAPI (marking all nucleated cells in blue) demonstrated that EPC take part in blood vessel formation within the fibrovascular tissue where they form part of the capillary lumina
Presence of EPC within intermuscular septae was confirmed in an analogous fashion (Fig. 7D-F) .
Abundant amounts of EPC could be detected in the spleen at 2 weeks after transplantation (Fig. 8A-C (Fig. 9A and B) . [4] . A similar mechanism could be enabled by the transplanted EPC themselves through the release of fibrinolytic enzymes, particularly matrix metalloproteinases [16] , leading to enhanced degradation of the matrix while the cells migrate through the matrix towards the fibrovascular tissue that is formed adjacent to the fibrin construct. This has previously been shown to be essential during the neovascularization process supported by cells derived from the endothelial lineage [16, 17] . [18] . In the past, platelet-rich plasma has been used to enhance wound healing, and increase in fibrovascular tissue formation has been attributed to the rich source of supportive growth factors contained within the platelets [19] . In our previous study using the same subcutaneous chamber implantation model we demonstrated enhanced fibrovascular tissue formation when recombinant growth factors VEGF and bFGF were suspended in the adjacent fibrin matrix [4] . EPC differentiate after in vivo transplantation under the influence of multiple local growth factors and cytokines and have been shown to be a rich source of growth factors supporting angiogenesis and proliferation themselves, potentially stimulating fibrovascular tissue formation in the present study. [14, 21, 22] . Investigating one identical single region of interest by triple fluorescence staining, we could show co-localization of EPC with the vessel wall of blood vessels that were newly formed within the fibrovascular tissue. This is in concordance with previous studies using the same murine EPC cell line where EPC were either associated with or even integrated in newly formed blood vessels after myocardial ischemia [14] and in tumours [12, 13] 
Distribution pattern and impact of T17b-lacZ on fibrin clot behaviour and fibrovascular tissue formation as well as blood vessel number and diameter were comparable to fluorescently labelled T17b EPC (data not shown).
Generation of fibrovascular tissue was efficiently stimulated by the addition of T17b EPC immobilized within the fibrin matrix, resulting in a significant increase in volume and height of fibrovascular tissue compared to cell-free clots at all observed time-points. In addition, quantification of blood vessels staining positive for lectin revealed that the angiogenic response was accelerated at early observation times: At days 3 and 7 after implantation, numbers of blood vessels were significantly increased in cell-containing fibrovascular tissue of the constructs, whereas the size of blood vessels was increased at all observation points. Altman et al. recently demonstrated that fibrovascular tissue formation can be efficiently stimulated by cell therapy as they delivered human adipose-derived stem cells to a murine soft tissue injury model, resulting in increased wound healing, microvessel density and adipose-derived stem cell differentiation into fibrovascular, endothelial and epithelial components of restored tissue
Fig. 6 Localization of DiI labelled T17b EPC in fibrin clot (A-C) and fibrovascular granulation tissue (D-F) at day 3 (A), (D), day 7 (B), (E) and day 14 (C), (F) by Fluorescence Microscopy. With increasing duration of the experiment, there was a shift of T17b cells from within the fibrin clot into the adjacent layers of tissue, i.e. to the granulation tissue and the adjacent intermuscular septae. At day 3, Di-I ϩ EPC appeared numerous and homogenously distributed within the clot, with only occasional cells within the newly formed granulation tissue (A versus D). The number of T17 EPC within the fibrin clot was decreased whereas there was an increase of cells within the granulation tissue at day 7 (B versus E). At day 14 after implantation, the vast majority of T17b EPC was located in the granulation tissue, whereas only a small number of cells were still present within the fibrin clot (C versus F).
cells derived from the host, and demonstrated localization of T17b cells in relation to the vascular network within the granulation tissue (A-C) and the underlying muscle (D-F). Integration of the transplanted cells into newly formed capillaries within the granulation tissue is demonstrated by co-localization of murine T17b EPC (red fluorescence) and blood vascular endothelium (green fluorescence) (A, B).
